Ligand · CQ0
CQ0 · 3-(3-tert-butyl[1,2,4]triazolo[4,3-a]pyridin-7-yl)-N-cyclopropyl-4-methylbenzamide
CQ0, 3-(3-tert-butyl[1,2,4]triazolo[4,3-a]pyridin-7-yl)-N-cyclopropyl-4-methylbenzamide (C21 H24 N4 O, 348.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5…
- Component
- CQ0
- Formula
- C21 H24 N4 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
CQ0 in 2 structures; the first of them:
- 3S3I · p38 kinase crystal structure in complex with small molecule inhibitor · CQ0 A1 · binds VAL30, VAL38, ALA51, VAL52, LYS53, GLU71, LEU74, LEU75 and 13 more
- 3S3I · P38 kinase crystal structure in complex with small molecule inhibitor · CQ0 A1 · binds VAL30, VAL38, ALA51, VAL52, LYS53, GLU71, LEU74, LEU75 and 13 more
Residues it binds most
LEU 2, ALA 2, VAL 2, ASP 2, GLU 2, GLY 2, HIS 2, ILE 2, LYS 2, PHE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.